Glycerol Monolaurate Inhibits Wild-Type African Swine Fever Virus Infection in Porcine Macrophages.

African swine fever virus antiviral glycerol monolaurate mitigation monoglyceride

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
25 Sep 2023
Historique:
received: 04 08 2023
revised: 08 09 2023
accepted: 22 09 2023
medline: 27 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

Naturally abundant antimicrobial lipids, such as fatty acids and monoglycerides, that disrupt membrane-enveloped viruses are promising mitigants to inhibit African swine fever virus (ASFV). Among mitigant candidates in this class, glycerol monolaurate (GML) has demonstrated particularly high antiviral activity against laboratory-adapted ASFV strains. However, there is an outstanding need to further determine the effects of GML on wild-type ASFV strains, which can have different virulence levels and sensitivities to membrane-disrupting compounds as compared to laboratory-adapted strains. Herein, we investigated the antiviral effects of GML on a highly virulent strain of a wild-type ASFV isolate (Armenia/07) in an in vitro porcine macrophage model. GML treatment caused a concentration-dependent reduction in viral infectivity, and there was a sharp transition between inactive and active GML concentrations. Low GML concentrations had negligible effect on viral infectivity, whereas sufficiently high GML concentrations caused a >99% decrease in viral infectivity. The concentration onset of antiviral activity matched the critical micelle concentration (CMC) value of GML, reinforcing that GML micelles play a critical role in enabling anti-ASFV activity. These findings validate that GML can potently inhibit wild-type ASFV infection of porcine macrophages and support a biophysical explanation to guide antimicrobial lipid performance optimization for pathogen mitigation applications.

Identifiants

pubmed: 37887709
pii: pathogens12101193
doi: 10.3390/pathogens12101193
pmc: PMC10610281
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Research Foundation of Korea
ID : 2020R1C1C1004385

Références

J Phys Chem Lett. 2020 Jul 2;11(13):4951-4957
pubmed: 32478524
PLoS One. 2015 Nov 30;10(11):e0142889
pubmed: 26618713
Antimicrob Agents Chemother. 1972 Jul;2(1):23-8
pubmed: 4670656
Front Microbiol. 2022 Dec 09;13:1059118
pubmed: 36569067
Front Vet Sci. 2023 Jan 27;10:980187
pubmed: 36777661
J Virol. 2014 Feb;88(3):1849-53
pubmed: 24284320
Emerg Infect Dis. 2019 May;25(5):891-897
pubmed: 30761988
Int J Mol Sci. 2023 Apr 27;24(9):
pubmed: 37175626
J Anim Sci Biotechnol. 2020 Apr 23;11:44
pubmed: 32337029
Int J Mol Sci. 2021 Sep 07;22(18):
pubmed: 34575831
PLoS Pathog. 2016 Apr 25;12(4):e1005595
pubmed: 27110717
Nat Rev Microbiol. 2015 Jul;13(7):426-37
pubmed: 26075364
ACS Nano. 2021 Jan 26;15(1):125-148
pubmed: 33306354
Foods. 2021 Sep 27;10(10):
pubmed: 34681338
PLoS One. 2016 Jul 08;11(7):e0158658
pubmed: 27391689
Transbound Emerg Dis. 2022 Jan;69(1):121-127
pubmed: 34698444
J Food Saf. 1982 Mar;4(1):1-12
pubmed: 32336838
Curr Protoc Cell Biol. 2011 Dec;Chapter 26:26.14.1-26.14.25
pubmed: 22161547
Front Vet Sci. 2022 Oct 13;9:980381
pubmed: 36311680
Molecules. 2022 Oct 26;27(21):
pubmed: 36364088
Transbound Emerg Dis. 2022 Sep;69(5):e1179-e1200
pubmed: 35104041
Langmuir. 2019 Mar 5;35(9):3568-3575
pubmed: 30720282
Science. 2019 Nov 1;366(6465):640-644
pubmed: 31624094
Langmuir. 2015 Sep 22;31(37):10223-32
pubmed: 26325618
Front Vet Sci. 2020 May 13;7:215
pubmed: 32478103
Sensors (Basel). 2022 May 13;22(10):
pubmed: 35632121
Nat Food. 2021 Oct;2(10):802-808
pubmed: 37117973
Transbound Emerg Dis. 2021 Mar;68(2):477-486
pubmed: 32613713
Viruses. 2022 Jun 24;14(7):
pubmed: 35891365
Emerg Infect Dis. 2008 Dec;14(12):1870-4
pubmed: 19046509
J Anim Sci Biotechnol. 2020 Dec 8;11(1):114
pubmed: 33292608
Virus Res. 2019 Sep;270:197669
pubmed: 31325472
mBio. 2020 May 5;11(3):
pubmed: 32371599
Front Microbiol. 2021 Oct 21;12:736780
pubmed: 34745038
Vaccines (Basel). 2019 Jan 28;7(1):
pubmed: 30696015
J Gen Virol. 2018 Jan;99(1):148-156
pubmed: 29235978
Front Vet Sci. 2021 Aug 02;8:689811
pubmed: 34409087
Viruses. 2017 May 10;9(5):
pubmed: 28489063

Auteurs

Joshua A Jackman (JA)

School of Chemical Engineering and Translational Nanobioscience Research Center, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Erik Arabyan (E)

Laboratory of Antiviral Drug Discovery, Institute of Molecular Biology of NAS, Yerevan 0014, Armenia.

Hovakim Zakaryan (H)

Laboratory of Antiviral Drug Discovery, Institute of Molecular Biology of NAS, Yerevan 0014, Armenia.

Charles C Elrod (CC)

Natural Biologics Inc., Newfield, NY 14867, USA.
Department of Animal Science, Cornell University, Ithaca, NY 14853, USA.

Classifications MeSH